Skip to main content
. 2020 Jan 24;40(1):BSR20193489. doi: 10.1042/BSR20193489

Figure 2. NORAD acted as a miR-129-1-3p sponge in NSCLC.

Figure 2

(A) The expression of miRNAs was appraised in cells transfected with sh-NORAD#1. (B) RNA pull-down assays were applied to see the combination between miRNAs and NORAD. (C) The binding sites between miR-129-1-3P and NORAD were shown by bioinformatics. (D) RIP assays were conducted to illustrate miR-129-1-3p and NORAD coexisted in RISCs. (E) The expression of miR-129-1-3p was examined in cells transfected with miR-129-1-3p mimics. (F) Luciferase reporter assays were conducted to prove the combination between miR-129-1-3p and NORAD. (G) MiR-129-1-3p expression was tested in NSCLC tissues and adjacent normal tissues. (H) MiR-129-1-3p expression was evaluated in DDP-sensitive and DDP-resistant tissues; **P < 0.01.